MEDICAL SCIENCEXamoterol in severe heart failure
References (15)
- et al.
Effects of a cardioselective beta1 partial agonist ('Corwin') with previous myocardial infarction
Am J Cardiol
(1983) Double-blind placebo controlled comparison of digoxin and xamoterol in chronic heart failure
Lancet
(1988)- et al.
Effects of captopril on survival in patients with heart failure
Am J Med
(1988) - et al.
The cardiovascular effects of ICI 118587: a beta1-adrenoceptor partial agonist
Br J Pharmacol
(1982) - et al.
Hemodynamic effects of β1 partial agonist xamoterol in relation to plasma norepinephrine levels during exercise in patients with left ventricular dysfunction
Circulation
(1987) - et al.
Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta1-adrenoceptor partial agonist, ICI 118,587
Europ Heart J
(1982) - et al.
Die akute Wirkung des kardioselektiven beta-1-partiellen Agonisten, 'Corwin', auf die Ventrikelfunktion und den myocardialen Sauerstoffverbrauch bei Patienten mit dilativer Kardiomyopathie
Z Kardiol
(1986)
There are more references available in the full text version of this article.
Cited by (489)
Sympathomodulation in congestive heart failure: From drugs to devices
2020, International Journal of CardiologyTreatment of Heart Failure with Abnormal Left Ventricular Systolic Function in Older Adults
2017, Heart Failure ClinicsThe Effect of inotropes and vasopressors on mortality: A meta-analysis of randomized clinical trials
2015, British Journal of AnaesthesiaCitation Excerpt :If we specifically consider acute or decompensated heart failure, the effect of inotropes is less defined. There are some evidences from observational studies that inotropes in general and catecholamines in particular could increase mortality.7–9 Moreover, in a meta-regression analysis, Thackray and colleagues11 found a non-significant increase in mortality associated with i.v. inotropes use, as compared with placebo or non-inotropic control.
Statistical Thinking for Non-Statisticians in Drug Regulation, THIRD EDITION
2023, Statistical Thinking for Non-Statisticians in Drug Regulation, Third EditionOptimal Management of Heart Failure and Chronic Obstructive Pulmonary Disease: Clinical Challenges
2022, International Journal of General MedicineInotropes and Vasopressors Use in Critical Care and Perioperative Medicine: Evidence-Based Approach (Review)
2022, Obshchaya Reanimatologiya
- 1
The names of organisers and participants are printed at the end of the paper. Correspondence to Prof Lars Rydén, MD, Division of Cardiology, Department of Medicine, Thoracic Clinics, Karolinska Hospital, S-104 01 Stockholm, Sweden.
Copyright © 1990 Published by Elsevier Ltd.